Zydus Cadila

Zydus Cadila to apply for COVID-19 vaccine trial on kids below 12 years of age

"The vaccine development journey starts by first trying it in adults, then adolescents, and then children. We will now file for a trial in children of the age group of 3-12 in the next 7-10 days."

DCGI to soon release recommendations on Zydus Cadila vaccine: Dr VK Paul

He also said that the vaccine will be approved for those above the age of 12 years if the scientific data indicates that the vaccine is safe.

Cadila Healthcare Q3 results: Profit increased by 41%

Zydus Cadila receives DCGI nod for Phase-I trial of ZYIL1

Zydus Cadila completes Phase II trials of its Alpha-2b

Zydus Cadila on Thursday announced that it has successfully completed Phase II clinical trial in CoVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, ‘PegiHepTM’.

Remdac: India’s cheapest Remdesivir version launched by Zydus Cadila to fight COVID-19

India's Zydus Cadila launched the cheapest Remdesivir version of COVID-19 anti-viral to fight the novel Coronavirus.